Integer Holdings Corporation (ITGR) Research

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

Market snapshot

Symbol
ITGR
Price
$90.96
Day change
+1.63%
Market cap
$3.1B
P/E ratio
22.40x
52-week range
62-123.78
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 1 month
Analyst price target
$108

Recent news

  • The High-Yield Stocks the Smart Money Is Buying Right Now

    There is a principle I have followed for 30 years in this business. When the smartest credit team on the planet starts aggressively buying a beaten-down asset class they understand better than anyone alive, you do not sit on your hands and debate whether the timing is perfect.

  • These Analysts Revise Their Forecasts On Integer Holdings After Q1 Results

    Integer Holdings Corp (NYSE:ITGR) reported better-than-expected first-quarter financial results on Thursday.

Peer companies

  • Addus HomeCare Corporation (ADUS)
  • Artivion, Inc. (AORT)
  • Concentra Group Holdings Parent, Inc. (CON)
  • Haemonetics Corporation (HAE)
  • Inspire Medical Systems, Inc. (INSP)
  • LivaNova PLC (LIVN)
  • Premier, Inc. (PINC)
  • PROCEPT BioRobotics Corporation (PRCT)

Recent insider activity

  • MAXWELL MARTIN C — A-Award (1967 shares) on 2026-05-20
  • Hinrichs James F. — A-Award (1967 shares) on 2026-05-20
  • COYLE MICHAEL J — A-Award (1967 shares) on 2026-05-20
  • Kapito Aaron — A-Award (1967 shares) on 2026-05-20
  • Jeffers Alvin Tyrone — A-Award (1967 shares) on 2026-05-20

Open Integer Holdings Corporation (ITGR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.